A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats

Published:2015 Issue:5 Volume:30 Page:559
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Chang Sung-A¹²^ORCID,Lim Byung-Kwan³,Lee You Jung¹,Hong Mi-Kyung²,Choi Jin-Oh¹²,Jeon Eun-Seok¹²^ORCID

Affiliation:

1. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Department of Biomedical Science, Jungwon University, Goesan-gun, Korea.

Funder

Boryung Pharmaceutical, Inc.

Korea Samsung Biomedical Research Institute

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

http://synapse.koreamed.org/pdf/10.3346/jkms.2015.30.5.559

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity;Frontiers in Physiology;2023-03-09

2. Fimasartan attenuates edema and systemic changes in egg albumin-induced paw inflammation in rats;Journal of Advanced Pharmacy Education and Research;2023

3. In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation;Journal of Cardiovascular Translational Research;2022-03-21

4. Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up;Clinical Science;2022-01

5. Protective effect of valsartan against doxorubicin‐induced cardiotoxicity: Histopathology and metabolomics in vivo study;Journal of Biochemical and Molecular Toxicology;2021-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3